Based near Atlanta, EndoChoice (NYSE: GI) is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists diagnosing and treating a wide range of gastrointestinal conditions, including colon cancer.
Future Diagnostics Solutions offers IVD (immuno) Assay Development and Contract Manufacturing Services to IVD multinationals, mid-sized biotech and small startup companies within the global medical diagnostic market and device industry.
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry.
Streamline reputation management: Aggregate reviews from multiple platforms and engage customers with our seamless reply feature, enhancing your brand's trust!